378 related articles for article (PubMed ID: 37503331)
1. Integrating scRNA and bulk-RNA sequencing develops a cell senescence signature for analyzing tumor heterogeneity in clear cell renal cell carcinoma.
Gong Q; Jiang Y; Xiong J; Liu F; Guan J
Front Immunol; 2023; 14():1199002. PubMed ID: 37503331
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma.
Lu C; Wang Y; Nie L; Chen L; Li M; Qing H; Li S; Wu S; Wang Z
Front Immunol; 2022; 13():934243. PubMed ID: 36189255
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis.
Yue Y; Cai X; Lu C; Sechi LA; Solla P; Li S
Front Immunol; 2023; 14():1238312. PubMed ID: 37908350
[TBL] [Abstract][Full Text] [Related]
4. SPCS, a Novel Classifier System Based on Senescence Axis Regulators Reveals Tumor Microenvironment Heterogeneity and Guides Frontline Therapy for Clear Cell Renal Carcinoma.
Jiang A; Liu Y; Zhu B; Fang Y; Qu L; Yang Q; Luo P; Cai C; Wang L
Clin Genitourin Cancer; 2024 Apr; 22(2):497-513. PubMed ID: 38245436
[TBL] [Abstract][Full Text] [Related]
5. Senescence gene expression in clear cell renal cell carcinoma: Role of tumor immune microenvironment and senescence-associated survival prediction.
Wu Y; Li X
Medicine (Baltimore); 2023 Oct; 102(40):e35222. PubMed ID: 37800815
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a metastasis-associated prognostic signature based on single-cell RNA-seq in clear cell renal cell carcinoma.
Zhang C; He H; Hu X; Liu A; Huang D; Xu Y; Chen L; Xu D
Aging (Albany NY); 2019 Nov; 11(22):10183-10202. PubMed ID: 31747386
[TBL] [Abstract][Full Text] [Related]
7. Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma.
Xia ZN; Wu JG; Yao WH; Meng YY; Jian WG; Wang TD; Xue W; Yu YP; Cai LC; Wang XY; Zhang P; Li ZY; Zhou H; Jiang ZC; Zhou JY; Zhang C
Sci Rep; 2022 Jun; 12(1):10973. PubMed ID: 35768519
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of UPF1 as a Novel Prognostic Biomarker in Renal Clear Cell Carcinoma.
Wu C; Li H; Chang W; Zhong L; Zhang L; Wen Z; Mai S
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421841
[No Abstract] [Full Text] [Related]
10. Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma.
Yu Z; Lv Y; Su C; Lu W; Zhang R; Li J; Guo B; Yan H; Liu D; Yang Z; Mi H; Mo L; Guo Y; Feng W; Xu H; Peng W; Cheng J; Nan A; Mo Z
Cancer Res; 2023 Mar; 83(5):700-719. PubMed ID: 36607615
[TBL] [Abstract][Full Text] [Related]
11. Identification of Treg-related prognostic molecular subtypes and individualized characteristics in clear cell renal cell carcinoma through single-cell transcriptomes and bulk RNA sequencing.
Weng KQ; Liu JY; Li H; She LL; Qiu JL; Qi H; Qi HY; Li YS; Dai YB
Int Immunopharmacol; 2024 Mar; 130():111746. PubMed ID: 38442575
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a Seven-Gene Signature Associated with CD8
Chen Y; Zhou X; Xie Y; Wu J; Li T; Yu T; Pang Y; Du W
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762031
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of necroptosis-related lncRNA signature with potential implications in tumor heterogeneity and prediction of prognosis in clear cell renal cell carcinoma.
Lin H; Qu L; Chen G; Zhang C; Lu L; Chen Y
Eur J Med Res; 2023 Jul; 28(1):236. PubMed ID: 37452355
[TBL] [Abstract][Full Text] [Related]
14. Single-cell transcriptome analysis revealing the intratumoral heterogeneity of ccRCC and validation of MT2A in pathogenesis.
Wang J; Zuo Z; Yu Z; Chen Z; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Jiang T; Ye F; Ma B; Sun Z
Funct Integr Genomics; 2023 Sep; 23(4):300. PubMed ID: 37713131
[TBL] [Abstract][Full Text] [Related]
15. Cellular senescence and metabolic reprogramming model based on bulk/single-cell RNA sequencing reveals PTGER4 as a therapeutic target for ccRCC.
Zhou L; Zeng Y; Liu Y; Du K; Luo Y; Dai Y; Pan W; Zhang L; Zhang L; Tian F; Gu C
BMC Cancer; 2024 Apr; 24(1):451. PubMed ID: 38605343
[TBL] [Abstract][Full Text] [Related]
16. Renal enhanced CT images reveal the tandem mechanism between tumor cells and immunocytes based on bulk/single-cell RNA sequencing.
Liang H; Wu K; Wu R; Huang K; Deng Z; Chen H
Funct Integr Genomics; 2023 Mar; 23(2):88. PubMed ID: 36933049
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma.
Wang K; Yu M; Zhang Z; Yin R; Chen Q; Zhao X; Yu H
Transl Cancer Res; 2023 May; 12(5):1270-1289. PubMed ID: 37304554
[TBL] [Abstract][Full Text] [Related]
18. Immune regulation and prognosis indicating ability of a newly constructed multi-genes containing signature in clear cell renal cell carcinoma.
Gui Z; Du J; Wu N; Shen N; Yang Z; Yang H; Wang X; Zhao N; Zeng Z; Wei R; Ma W; Wang C
BMC Cancer; 2023 Jul; 23(1):649. PubMed ID: 37438709
[TBL] [Abstract][Full Text] [Related]
19. Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal Cell Carcinoma Patients.
Saout JR; Lecuyer G; Léonard S; Evrard B; Kammerer-Jacquet SF; Noël L; Khene ZE; Mathieu R; Brunot A; Rolland AD; Bensalah K; Rioux-Leclercq N; Lardenois A; Chalmel F
Eur Urol; 2023 May; 83(5):441-451. PubMed ID: 36801089
[TBL] [Abstract][Full Text] [Related]
20. Identification of Ligand-Receptor Pairs Associated With Tumour Characteristics in Clear Cell Renal Cell Carcinoma.
Liu F; Wang P; Sun W; Jiang Y; Gong Q
Front Immunol; 2022; 13():874056. PubMed ID: 35734169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
